Crimean-Congo hemorrhagic fever
MONDO:0020501Crimean-Congo hemorrhagic fever (CCHF) is a tick-borne zoonotic disease caused by CCHF virus and characterized by initial fever, headache, and malaise followed by gastrointestinal symptoms and, in severe cases, bleeding, shock, and multi-organ system failure.
Also known as: CCHF, Congo fever, Congo hemorrhagic fever, Congo-Crimean hemorrhagic fever, Crimean hemorrhagic fever, Crimean hemorrhagic fever [CHF Congo virus], Crimean-Congo haemorrhagic fever
8 clinical trials for this condition and its sub-types, 5 tagged with Crimean-Congo hemorrhagic fever itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
First human trial launches for DNA vaccine against deadly CCHF virus
Vaccine CompletedThis early-stage trial tested a new DNA vaccine called N-pVAX1 against Crimean-Congo hemorrhagic fever (CCHF), a severe viral disease. Fifteen healthy adults received three doses of the vaccine over 12 weeks. The main goal was to check safety and side effects, while also measurin…
Phase 1 • Sponsor: Karolinska Institutet • Aim: Vaccine
Last updated Jun 27, 2026 12:00 UTC
-
Can a 15-Minute test stop a deadly virus in its tracks?
Diagnosis CompletedThis trial evaluates a new rapid diagnostic test designed to detect Crimean-Congo hemorrhagic fever (CCHF) at the point of care. The test aims to provide results in minutes instead of the current 2-5 days, which could speed up treatment and reduce the risk of the disease spreadin…
Sponsor: Liverpool School of Tropical Medicine • Aim: Diagnosis
Last updated Aug 29, 2026 00:00 UTC